Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia 30333, USA.
Am J Prev Med. 2010 Apr;38(4 Suppl):S495-501. doi: 10.1016/j.amepre.2009.12.017.
Venous thromboembolism (VTE), defined as deep vein thrombosis, pulmonary embolism, or both, affects an estimated 300,000-600,000 individuals in the U.S. each year, causing considerable morbidity and mortality. It is a disorder that can occur in all races and ethnicities, all age groups, and both genders. With many of the known risk factors-advanced age, immobility, surgery, obesity-increasing in society, VTE is an important and growing public health problem. Recently, a marked increase has occurred in federal and national efforts to raise awareness and acknowledge the need for VTE prevention. Yet, many basic public health functions-surveillance, research, and awareness-are still needed. Learning and understanding more about the burden and causes of VTE, and raising awareness among the public and healthcare providers through a comprehensive public health approach, has enormous potential to prevent and reduce death and morbidity from deep vein thrombosis and pulmonary embolism throughout the U.S.
静脉血栓栓塞症(VTE)定义为深静脉血栓形成、肺栓塞或两者兼有,每年在美国影响约 30 万至 60 万人,导致相当大的发病率和死亡率。这是一种可以发生在所有种族和民族、所有年龄段和性别的疾病。随着许多已知的风险因素——年龄增长、不活动、手术、肥胖——在社会中不断增加,VTE 是一个重要且日益严重的公共卫生问题。最近,联邦和国家在提高认识和认识到预防 VTE 的必要性方面做出了显著努力。然而,仍有许多基本的公共卫生职能——监测、研究和意识——是必要的。通过全面的公共卫生方法,更多地了解 VTE 的负担和原因,并提高公众和医疗保健提供者的意识,具有巨大的潜力,可以预防和减少美国深静脉血栓形成和肺栓塞导致的死亡和发病率。